204 related articles for article (PubMed ID: 25706725)
21. Mannitol-adenine-phosphate: a novel solution for intraoperative blood salvage.
Yang P; Zhou J; Kang Y; Gong L; Zhang J; Yu J; Yin X; Zhang C; Liu G; Liu J; Du L
Transfusion; 2014 Apr; 54(4):1146-52. PubMed ID: 23927791
[TBL] [Abstract][Full Text] [Related]
22. Survival of the fittest?--survival of stored red blood cells after transfusion.
Luten M; Roerdinkholder-Stoelwinder B; Bost HJ; Bosman GJ
Cell Mol Biol (Noisy-le-grand); 2004 Mar; 50(2):197-203. PubMed ID: 15095790
[TBL] [Abstract][Full Text] [Related]
23. Properties of donated red blood cell components from patients with hereditary hemochromatosis.
Sut C; Hamzeh-Cognasse H; Laradi S; Bost V; Aubrège C; Acquart S; Vignal M; Boutahar N; Arthaud CA; Ange Eyraud M; Pozzetto B; Tiberghien P; Garraud O; Cognasse F
Transfusion; 2017 Jan; 57(1):166-177. PubMed ID: 27807848
[TBL] [Abstract][Full Text] [Related]
24. Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method.
Lu FQ; Kang W; Peng Y; Wang WM
Transfusion; 2011 Oct; 51(10):2199-207. PubMed ID: 21492181
[TBL] [Abstract][Full Text] [Related]
25. [49 day storage of erythrocyte concentrates in blood bags with the PAGGS-mannitol solution].
Walker WH; Netz M; Gänshirt KH
Beitr Infusionsther; 1990; 26():55-9. PubMed ID: 1703901
[TBL] [Abstract][Full Text] [Related]
26. Damage to red blood cells during whole blood storage.
Oh JY; Marques MB; Xu X; Li J; Genschmer K; Gaggar A; Jansen JO; Holcomb JB; Pittet JF; Patel RP
J Trauma Acute Care Surg; 2020 Aug; 89(2):344-350. PubMed ID: 32301878
[TBL] [Abstract][Full Text] [Related]
27. Influence of irradiation on in vitro red-blood-cell (RBC) storage variables of leucoreduced RBCs in additive solution PAGGS-M.
Hauck B; Oremek D; Zimmermann R; Ruppel R; Troester B; Eckstein R
Vox Sang; 2011 Jul; 101(1):21-7. PubMed ID: 21155835
[TBL] [Abstract][Full Text] [Related]
28. Compatibility of ADSOL-stored red cells with intravenous solutions.
Strautz RL; Nelson JM; Meyer EA; Shulman IA
Am J Emerg Med; 1989 Mar; 7(2):162-4. PubMed ID: 2493255
[TBL] [Abstract][Full Text] [Related]
29. Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process.
Cancelas JA; Dumont LJ; Rugg N; Szczepiorkowski ZM; Herschel L; Siegel A; Pratt PG; Worsham DN; Erickson A; Propst M; North A; Sherman CD; Mufti NA; Reed WF; Corash L
Transfusion; 2011 Nov; 51(11):2367-76. PubMed ID: 21569044
[TBL] [Abstract][Full Text] [Related]
30. Exploratory in vitro study of red blood cell storage containers formulated with an alternative plasticizer.
Dumont LJ; Baker S; Dumont DF; Herschel L; Waters S; Calcagni K; Sandford C; Radwanski K; Min K; David RM; Otter R
Transfusion; 2012 Jul; 52(7):1439-45. PubMed ID: 22211692
[TBL] [Abstract][Full Text] [Related]
31. Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability: results of a two-centre study.
Cancelas JA; Gottschall JL; Rugg N; Graminske S; Schott MA; North A; Huang N; Mufti N; Erickson A; Rico S; Corash L
Vox Sang; 2017 Apr; 112(3):210-218. PubMed ID: 28220519
[TBL] [Abstract][Full Text] [Related]
32. Prolonged maintenance of 2,3-diphosphoglycerate acid and adenosine triphosphate in red blood cells during storage.
de Korte D; Kleine M; Korsten HG; Verhoeven AJ
Transfusion; 2008 Jun; 48(6):1081-9. PubMed ID: 18373504
[TBL] [Abstract][Full Text] [Related]
33. Feasibility and safety of AS-3 red blood cells for neonatal transfusions.
Strauss RG; Burmeister LF; Johnson K; Cress G; Cordle D
J Pediatr; 2000 Feb; 136(2):215-9. PubMed ID: 10657828
[TBL] [Abstract][Full Text] [Related]
34. Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions.
Hansen A; Yi QL; Acker JP
Transfusion; 2013 Aug; 53(8):1772-9. PubMed ID: 23521180
[TBL] [Abstract][Full Text] [Related]
35. Clinical usefulness of red cells preserved in protein-poor mediums.
Högman CF; Hedlund K; Zetterström H
N Engl J Med; 1978 Dec; 299(25):1377-82. PubMed ID: 714116
[TBL] [Abstract][Full Text] [Related]
36. In vitro evaluation of the quality of blood products collected and stored in systems completely free of di(2-ethylhexyl)phthalate-plasticized materials.
Lagerberg JW; Gouwerok E; Vlaar R; Go M; de Korte D
Transfusion; 2015 Mar; 55(3):522-31. PubMed ID: 25331824
[TBL] [Abstract][Full Text] [Related]
37. Transfusion-related biologic effects and free hemoglobin, heme, and iron.
Ozment CP; Mamo LB; Campbell ML; Lokhnygina Y; Ghio AJ; Turi JL
Transfusion; 2013 Apr; 53(4):732-40. PubMed ID: 22882431
[TBL] [Abstract][Full Text] [Related]
38. Storage of red cell concentrates in CPD-A2 for 42 and 49 days.
Beutler E; West C
J Lab Clin Med; 1983 Jul; 102(1):53-62. PubMed ID: 6854134
[TBL] [Abstract][Full Text] [Related]
39. Viability of AS-3 and SAG-M red cells stored in plastic syringes for pediatric transfusion.
Podlosky L; Poirier A; Nahirniak S; Clarke G; Acker JP
Transfusion; 2008 Jul; 48(7):1300-7. PubMed ID: 18363582
[TBL] [Abstract][Full Text] [Related]
40. [Metabolic and rheologic changes in long-term hypothermia of erythrocyte concentrates over 15 weeks].
Matthes G; Richter E; Tofoté U; Kucera W; Lerche D
Beitr Infusionsther Transfusionsmed; 1994; 32():34-40. PubMed ID: 9480121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
